Biotoscana confirms sales talks

Biotoscana confirms sales talks

M&A Capital Markets Equity Brazil US Canada

Brazil's Biotoscana has confirmed that its controlling shareholders, Advent International and Essex Woodlands, are in talks to sell the São Paulo-based pharmaceutical company. Advent and Essex "have been negotiating with certain investors, but no decision related to any possible transaction involving the sale of control with any investor has been concluded to date," Biotoscana said in a securities filing. The online publication Brazil Journal reported earlier this week that Canada's Knight Thera

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial